Product Wiki · Recalls · EU Safety Gate (RAPEX)

Produto clareador de pele "Caro white Lightening bea" — recall A12/0875/12

EU Safety Gate (RAPEX) · Portugal · 2012-06-15 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/0875/12
Date of alert
2012-06-15
Country / jurisdiction
Portugal
Risk level
Serious risk
Risk type
Chemical
Brand
Angel Cosmetics
Product category
Cosmetics
Product type
Skin lightening product "Caro white Lightening bea
Reported risk: O produto apresenta risco químico porque contém o ingrediente hidroquinona, conforme declarado no rótulo, cuja utilização é proibida em cosméticos e produtos de higiene pessoal. O produto não está em conformidade com a Diretiva de Cosméticos 76/768/CEE.
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Skin lightening product "Caro white Lightening bea

Risk Description (original English): The product poses a chemical risk because it contains the ingredient hydroquinone, as declared on the label, the use of which is prohibited in cosmetics and personal hygiene products.The product does not comply with the Cosmetics directive 76/768/EEC.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/35180

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.